The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability.
Dr. Srishti Joshi
Advertisement
Dr. Srishti Joshi is postdoctoral fellows at Centre of Excellence, Biopharmaceutical Technology, Indian Institute of Technology New Delhi.
Articles by Dr. Srishti Joshi
Advertisement
Latest Updated Articles
Emergence of India as a Global Manufacturing Hub for BiosimilarsPublished: November 1st 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
